Trulieve Cannabis Corp. — Q2 2022 Form 10-Q
Reporting period: Three and six months ended June 30, 2022; filed August 10, 2022. Amounts below are in U.S. dollars unless noted. Trulieve is a vertically integrated, multi-state cannabis operator, with most revenue from Florida and additional operations expanded by the 2021 Harvest acquisition.
Financial performance
| Metric | Q2 2022 | Q2 2021 | Six months 2022 | Six months 2021 |
|---|---|---|---|---|
| Revenue | $320.3 million | $215.1 million | $638.6 million | $408.9 million |
| Gross profit / margin | $182.2 million / 57% | $144.5 million / 67% | $360.3 million / 56% | $279.7 million / 68% |
| Operating income | $38.0 million | $76.3 million | $66.6 million | $148.9 million |
| Net income (loss), attributable to common shareholders | $(22.5) million | $40.9 million | $(54.5) million | $71.0 million |
| Adjusted EBITDA | $111.0 million | $94.9 million | $216.5 million | $185.7 million |
- Revenue rose 49% in Q2 and 56% year to date, reflecting acquisitions, store growth, higher patient counts and product availability, and wholesale expansion. Retail generated $298.6 million of Q2 revenue; wholesale, licensing and other generated $21.7 million.
- Gross margin contracted as cost of goods sold rose faster than revenue. Management cited higher depreciation, new facilities not yet at scale, wholesale mix and sales of third-party products in markets that are not fully vertically integrated.
- Operating expenses increased substantially: Q2 sales and marketing was $75.3 million, G&A $33.7 million, and depreciation and amortization $30.9 million. Q2 interest expense was $19.7 million.
- The Q2 income tax provision was $44.8 million on pretax income of $20.7 million; the reported effective tax rate was 216%. For the first half, tax expense was $87.1 million on pretax income of $30.6 million, a 285% rate. Management notes the impact of cannabis tax restrictions under IRC Section 280E.
Cash, debt and liquidity
- Cash and cash equivalents were $181.4 million at June 30, 2022, down from $230.6 million at year-end 2021. Current assets were $530.0 million and current liabilities $165.4 million.
- First-half operating cash flow was negative $10.3 million, versus positive $49.2 million a year earlier. The company attributed the change mainly to the net loss, inventory and other working-capital needs, and income-tax payments. Investing cash outflow was $136.4 million, mainly for property and equipment; financing provided $94.4 million.
- Private placement notes had $555 million of principal outstanding ($539.0 million net carrying value), including 8% notes maturing in 2026. Notes payable were $13.0 million gross. The balance sheet also included $139.3 million of operating lease liabilities, $86.2 million of finance lease liabilities, and $183.2 million of construction finance liabilities.
- Management said existing cash was expected to cover anticipated requirements for at least the next 12 months. It may seek additional debt or equity for longer-term needs; availability and acceptable terms are not assured.
Material changes, outlook and risks
- Compared with 2021, revenue grew but profitability weakened: the company moved from net income to net loss, while operating income fell and gross margin declined. Adjusted EBITDA increased, but it is a non-GAAP measure and includes adjustments for items such as integration, acquisition, share-based compensation and asset impairment/disposals.
- Q2 included $4.3 million of impairment and disposal expense; first-half expense was $18.1 million, primarily associated with exited or repositioned facilities. The company also accrued $7.3 million for probable Watkins acquisition earnouts.
- In July 2022, Trulieve decided to discontinue Nevada wholesale operations and was evaluating its exit plans and financial impacts. At June 30, those operations represented approximately $54.6 million of assets and had generated $1.8 million of first-half revenue.
- No specific revenue or earnings guidance was provided. Management expects continued investment in stores, facilities, infrastructure and compliance, and anticipates ongoing acquisition, integration and public-company costs.
- Key risks include cannabis remaining illegal under U.S. federal law, potential asset forfeiture and regulatory or licensing consequences, Section 280E taxation, restricted access to banking, competition, inflation and weaker consumer demand. The filing reports $13.1 million of accrued litigation contingencies and $1.6 million related to sales-tax matters; it states no pending or threatened lawsuit was expected to materially affect results.
- Management reported that disclosure controls and procedures were not effective at June 30 because previously identified material weaknesses in internal control over financial reporting were still being remediated. Management said the financial statements fairly present the reported periods and described remediation actions, but additional time was needed to complete and assess them.
Important facts for investors to verify
- Whether the revenue gains can translate into restored gross margins and positive GAAP earnings as new facilities mature and product mix changes.
- Drivers of the unusually high effective tax rate, cash taxes paid, and the continued impact of Section 280E.
- Cash generation and working-capital trends, particularly inventory growth, alongside planned capital spending and debt-service obligations.
- The eventual costs and asset or impairment consequences of the Nevada wholesale exit, and progress on the Watkins earnouts.
- Remediation and independent assessment of the material weaknesses in financial reporting controls.
- Developments in cannabis federal and state regulation, licensing, litigation and inflation or demand risks.